BIOCON LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.5 INR | +0.03% |
|
+13.15% | +22.89% |
| 18/04 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
| 18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOCON LIMITED | Bio Therapeutic Drugs | +0.03% | +13.15% | +22.89% | +28.42% | +3.39% | 4.39B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited
- Comparison Chart
